Oxidation enhances human serum albumin thermal stability and changes the routes of amyloid fibril formation

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Sancataldo, Giuseppe ^a   Vetri, Valeria ^a,b   Foderà, Vito ^c,d   Cara, Gianluca Di ^e   Militello, Valeria ^a,b   Leone, Maurizio ^a,b  

^a UNIVERSITY OF PALERMO   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e Centro di Oncobiologia Sperimentale   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; HUMAN SERUM ALBUMIN; HYDROGEN PEROXIDE;

ARTICLE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; HUMAN; HYDROPHOBICITY; OXIDATION; OXIDATIVE STRESS; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; PROTEIN SECONDARY STRUCTURE; PROTEIN TERTIARY STRUCTURE; SPECTROSCOPY; THERMOSTABILITY;

AMYLOID; HUMANS; HYDROGEN PEROXIDE; KINETICS; OXIDATION-REDUCTION; PROTEIN MULTIMERIZATION; PROTEIN STABILITY; PROTEIN STRUCTURE, SECONDARY; SERUM ALBUMIN; TEMPERATURE;

EID: 84897130151     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084552     Document Type: Article

References (91)

1. Stefani M (2004) Protein misfolding and aggregation: new examples in medicine and biology of the dark side of the protein world. Biochim Biophys Acta 1739(1):5-25.
2. Chiti F, Dobson CM (2006) Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem. 75:333-66. (Pubitemid 44118036)
3. Karve TM, Cheema AK (2011) Small Changes Huge Impact: The Role of Protein Posttranslational Modifications in Cellular Homeostasis and Disease. Journal of Amino Acids 207691.
4. Wickner S, Maurizi MR, Gottesman S (1999) Posttranslational Quality Control: Folding, Refolding, and Degrading Proteins. Science 3 286:1888-1893. (Pubitemid 129515889)
5. Stadtman ER (2001) Protein Oxidation in Aging and Age-Related Diseases. Annals of the New York Academy of Sciences 928: 22-38.
6. Smith CD, Carney JM, Starke-Reed PE, Oliver CN, Stadtman ER, et al. (1991) Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc. Natl. Acad. Sci. USA 88: 10540-10543. (Pubitemid 21915871)
7. Stadtman ER, Starke-Reed PE, Oliver CN, Carney JM, Floyd RA (1992) Protein modification in aging. EXS.;62: 64-72.
8. Squier TC (2001) Oxidative stress and protein aggregation during biological aging. Exp Gerontol. 36(9): 1539-50.
9. Beal MF (2002) Oxidatively Modified Proteins in Aging and Disease. Free Radical Biology & Medicine 32(9):-797803.
10. Herczenik E, Gebbink MFBG (2008) Molecular and cellular aspects of protein misfolding and disease. FASEB J 22:2115-2133. (Pubitemid 351948631)
11. Markesbery WR, Carney JM (1999) Oxidative Alterations in Alzheimer's Disease. Brain Pathol. 9: 133-146.B (Pubitemid 29056524)
12. Browne SE, Ferrante RJ, Beal MF (1999) Oxidative stress in Huntington's disease. Brain Pathol. 9: 147-163. (Pubitemid 29056525)
13. Duda JE, Giasson BI, Chen Q, Gur TL, Hurtig HI, et al (2000) Widespread Nitration of Pathological Inclusions in Neurodegenerative Synucleinopathies. Am. J. Pathol. 157: 1439-1445
14. Ross CA, Poirier MA (2005) What Is the Role of Protein Aggregation in Neurodegeneration? Nat. Rev. Mol. Cell Biol., 6, 891-898. (Pubitemid 41568738)
15. Berlett BS, Stadtman ER (1997) Protein oxidation in aging, disease and oxidative stress. J BiolChem 272: 20313-20316. (Pubitemid 27355575)
16. Ames BN, Shigenaga MK, Hagen TM (1993) Oxidants, antioxidants, and the degenerative diseases of aging. PNAS 90, 7915-7922. (Pubitemid 23260825)
17. Xie H, Hou S, Jiang J, Sekutowicz M, Kelly, et al. (2013) Rapid cell death is preceded by amyloid plaque-mediated oxidative stress. PNAS published ahead of print April 22, 2013.
18. Barnham KJ, Ciccotosto GD, Tickler AK, Ali FE, Smith DG, et al. (2003) Neurotoxic, redox-competent Alzheimer's beta-amyloid is released from lipid membrane by methionine oxidation. JOURNAL OF BIOLOGICAL CHEMISTRY 278(44):42959-42965. (Pubitemid 37345908)
19. Ramirez-Alvarado M, Kelly W, Dobson (2010) Role of Oxidative Stress in Protein Misfolding and/or Amyloid Formation, in Protein Misfolding Diseases: Current and Emerging Principles and Therapies. John Wiley & Sons USA.
20. Stadtman ER, Van Remmen H, Richardson A, Wehr NB, Levine RL (2005) Methionine oxidation and aging. Biochim Biophys Acta: 1703-135.
21. Stadtman ER (1993) Oxidation of free amino acids and amino acid residues in proteins by radiolysis and by metal-catalyzed reactions. Annu Rev Biochem. 62: 797-821.
22. Bourdon E, Blache D (2001) The importance of proteins in defence against oxidation. Antioxid. Redox Signal. 3(2): 293-311. (Pubitemid 32473344)
23. Vogt W (1995) Oxidation of methionyl residues in proteins: Tools, targets, and reversal. Free Radical Biol. Med. 18: 93-105.
24. Sun H, Gao J, Ferrington DA, Biesiada H, Williams TD, et al. (1999) Repair of oxidized calmodulin by methionine sulfoxidereductase restores ability to activate the plasma membrane Ca-ATPase. Biochemistry. 5;38(1): 105-12.
25. Kay MS, Baldwin RL (1996) Packing interactions in the apomyglobin folding intermediate. Nat Struct Biol. 3(5):439-45. (Pubitemid 26139443)
26. Fleming PJ, Richards FM (2000) Protein packing: dependence on protein size, secondary structure and amino acid composition. J MolBiol 299: 487-498.
27. Jahn TR, Radford ES (2005) The Yin and Yang of protein folding. FEBS Journal 272: 5962-5970. (Pubitemid 41713688)
28. Eichner T, Radford SE (2011) Diversity of Assembly Mechanisms of a Generic Amyloid Fold. Mol Cell. 43(1): 8-18.
29. Uversky VN, Yamin G, Souillac PO, Goers J, Glaser CB, et al. (2002) Methionine oxidation inhibits fibrillation of human alpha-synuclein in vitro. FEBS Letters 517: 239-244. (Pubitemid 34327667)
30. Hou L, Kang I, Marchant RE, Zagorski MG (2002) Methionine 35 Oxidation Reduces Fibril Assembly of the Amyloid Ab(1-42) Peptide of Alzheimer's Disease. The Journal of biological chemistry 277(43): 40173-40176. (Pubitemid 35215584)
31. Maleknia SD, Reixach N, Buxbaum JN (2006) Oxidation inhibits amyloid fibril formation of transthyretin. FEBS Journal 273: 5400-5406. (Pubitemid 44772396)
32. Binger KJ, Griffin MDW, Howlett GJ (2008) Methionine Oxidation Inhibits Assembly and Promotes Disassembly of Apolipoprotein C-II Amyloid Fibrils. Biochemistry 47: 10208-10217.
33. Wong YQ, Binger KJ, Howlett G, Griffin MDW (2010) Methionine oxidation induces amyloid fibril formation by full-length apolipoprotein A-I. PNAS 107(5): 1977-1982.
34. Koudelka T, Dehle FC, Musgrave IF, Hoffmann P, Carver JA (2012) Methionine Oxidation Enhances k-Casein Amyloid Fibril Formation. J. Agric. Food Chem., 60: 4144-4155.
35. Vetri V, Librizzi F, Leone M, Militello V (2007) Thermal aggregation of bovine serum albumin at different pH: comparison with human serum albumin. EurBiophys J 36: 717-725. (Pubitemid 350092526)
36. Juarez J, Taboada P, Mosquera V (2009) Existence of Different Structural Intermediates on the Fibrillation Pathway of Human Serum Albumin. Biophysical Journal 96: 2353-2370.
37. Juarez J, Taboada P, Goy-Lopez S, Cambon A, Madec MB, et al. (2009) Additional Supra-Self-Assembly of Human Serum Albumin under Amyloid-Like-Forming Solution Condition. J. Phys. Chem. B, 113: 12391-12399.
38. Juarez J, Lopez SG, Camboon A, Taboada P, Mosquera V (2009) Influence of Electrostatic Interactions on the Fibrillation Process of Human Serum Albumin. J. Phys. Chem. B, 113 (30): 10521-10529.
39. Halliwell B (1998) Albumin - An important extracellular antioxidant?. Biochemical Pharmacology, 37(4): 569-571.
40. Roche M, Rondeau P, Singh NR, Tarnus E, Bourdon E (2008) The antioxidant properties of serum albumin. FEBS Letters 582: 1783-1787.
41. Carter DC, Ho JX (1994) Structure of Serum Albumin. Adv. Protein Chem. 45: 153-203. (Pubitemid 24139888)
42. Peters T (1996) All About Albumin: Biochemistry, Genetics and Medical Application. Academic Press, New York.
43. Katchalski E, Benjamin GS, Gross V (1957) The Availability of the Disulfide Bonds of Human and Bovine Serum Albumin and of Bovine gamma-Globulin to Reduction by Thioglycolic Acid. J. Am. Chem. Soc. 79: 4096-4099.
44. Zolese G, Falcioni G, Bertoli E, Galeazzi R, Wozniak M, et al. (2000) Steady-state and time resolved fluorescence of albumins interacting with N-oleylethanolamine, a component of the endogenous N-Acylethanolamines. Proteins 40(1): 39-4.
45. Iwao Y, Anraku M, Hiraike M, Kawai K, Nakajou K, et al. (2006) The structural and pharmacokinetic properties of oxidized human serum albumin, advanced oxidation protein products (AOPP). Drug MetabPharmacokinet. 21(2): 140-6.
46. Levine RL, Mosoni L, Berlett BS, Stadtman ER (1996) Methionine residues as endogenous antioxidants in proteins. PNAS USA. 93(26): 15036-40. (Pubitemid 27009547)
47. Levine RL, Berlett BS, Moskovitz J, Mosoni L, Stadtman ER (1999) Methionine residues may protect proteins from critical oxidative damage. Mech Ageing Dev. 107(3): 323-32.
48. Bourdon E, Loreau N, Lagrost L, Blanche D (2005) Differential effect of cysteine and mathionine residues in the antioxidant activity of human serum albumin. Free Radical Reseach 39(1): 15-20. (Pubitemid 40309466)
49. Shacter E (2000) Quantification and significance of protein oxidation in biological samples. Drug Metab Rev. 32(3-4): 307-26.
50. Lasch P, Petras T, Ullrich O, Backmann J, Naumann D, et al. (2001) Hydrogen peroxide-induced structural alterations of RNAse A. J Biol Chem. 276(12): 9492-502.
51. Ravi J, Hills AE, Cerasoli E, Rakowska PD, Ryadnov MG (2011) FTIR markers of methionine oxidation for early detection of oxidized protein therapeutics. Eur Biophys J 40: 339-345.
52. Shechter Y, Burstein Y, Patchornik A (1975) Selective oxidation of methionine residues in proteins. Biochemistry? 14(20): 4497-503.
53. Finch JW, Crouch RK, Knapp DR, Schey KL (1993) Mass spectrometric identification of modifications to human serum albumin treated with hydrogen peroxide. Arch BiochemBiophys. 305(2): 595-9. (Pubitemid 23282951)
54. Barth A (2007) Infrared spectroscopy of proteins. BiochimBiophysActa. 1767(9): 1073-101.
55. Militello V, Vetri V, Leone M (2003) Conformational changes involved in thermal aggregation processes of Bovine Serum Albumin. Biophys. Chem. 105: 133-141. (Pubitemid 36970268)
56. Lakowicz JR (2006) Principles of fluorescence spectroscopy, Third Edition, Springer.
57. Chen Y, Barkley MD (1998) Toward understanding tryptophan fluorescence in proteins. Biochemistry. 37(28): 9976-82. (Pubitemid 28366351)
58. Goswami N, Makhal A, Pal SK (2010) Toward an Alternative Intrinsic Probe for Spectroscopic Characterization of a Protein. J. Phys. Chem. B, 114: 15236-15243.
59. Stryer L (1965) The interaction of a naphthalene sulfonate dye with apomyoglobin and apohemoglobin: a fluorescence probe of non polar binding site. J. Mol. Biol. 13: 482-495.
60. Daniel E, Weber G (1966) Cooperative effects in binding by bovine serum albumin, I: the binding of 1-anilino-8-naphthalenesulfonate. Fluorimetric titrations. Coop Effects Binding Albumin 5:1893-1900
61. Semisotnov GV, Rodionova NA, Razgulyaev OI, Uversky VN, Gripas AF, et al. (1991) Study of the "Molten Globule" intermediate state in protein folding by a hydrophobic fluorescent probe. Biopolymers 31: 119-128.
62. Booth DR, Sunde M, Bellotti V, Robinson CV, Hutchinson WL, et al. (1997) Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis. Nature 385:787-793 (Pubitemid 27106061)
63. Bismuto E, Irace G, Sirangelo I, Gratton E (1996) Pressure-induced perturbation of ANS-apomyoglobin complex: frequency domain fluorescence studies on native and acidic compact states. Protein Sci. 5(1):121-6. (Pubitemid 26022074)
64. Vetri V, Canale C, Relini A, Librizzi F, Militello V, et al. (2007) Amyloid fibrils formation and amorphous aggregation in concanavalin A. Biophys Chem. 125, 184-190. (Pubitemid 44709396)
65. Bagatolli LA, Kivatinitz SC, Aguilar F, Soto MA, Sotomayor P, et al. (1996) Two distinguishable fluorescent mode of 1-anilino-8-naphthalene sulfonate bound to human albumin. Juournal of fluorescence 6(1): 33-40.
66. Meucci E, Mordente A, Martorana GE (1991) Metal-catalyzed oxidation of human serum albumin: conformational and functional changes. Implications in protein aging. J BiolChemMar 15;266(8):4692-9.
67. Schmit JD, Ghosh K, Dill K (2011) What drives amyloid molecules to assemble into oligomers and fibrils?. Biophys J.100:450-8.
68. Foderà V, Zaccone A, Lattuada M, Donald AM (2013) Electrostatics controls the formation of amyloid superstructures in protein aggregation. Physical Review Letters. 111, 108105.
69. Taboada P, Barbosa S, Castro E, Mosquera V (2006) Amyloid Fibril Formation and Other Aggregate Species Formed by Human Serum Albumin. The Journal of physical chemistry B 110: 20733-20736. (Pubitemid 44797322)
70. Foderà V, Librizzi F, Groenning M, van de Weert M, Leone M (2008) Secondary nucleation and accessible surface in insulin amyloid fibril formation. J PhysChem B;112(12):3853-8.
71. Vetri V, D'Amico M, Foderà V, Leone M, Ponzoni A, et al. (2011) Bovine Serum Albumin protofibril-like aggregates formation: solo but not simple mechanism. Arch Biochem Biophys.;508(1):13-24.
72. Carrotta R, Vetri V, Librizzi F, Martorana V, Militello V, et al. (2011) Amyloid fibrils formation of concanavalin A at basic pH. J PhysChem B;115(12):2691-8.
73. Vetri V, Leone M, Morozova-Roche LA, Vestergaard B, Foderà V (2013) Unlocked Concanavalin A Forms Amyloid-like Fibrils from Coagulation of Long-lived "Crinkled" Intermediates. PLoS ONE 8(7): e68912.
74. Vetri V, Militello V (2005) Thermal induced conformational changes involved in the aggregation pathways of beta-lactoglobulin. BiophysChem 113: 83-91. (Pubitemid 40029722)
75. Moriyama Y, Ohta D, Hachiya K, Mitsui Y, Takeda K (1996) Fluorescence behaviour of tryptophan residues of bovine and human serum albumins in ionic surfactant solutions: A comparative study of the two and one tryptophan(s) of bovine and human Albumins J. Prot. Chem. 15: 265-271.
76. Duy C, Fitter J (2006) How Aggregation and Conformational Scrambling of Unfolded States Govern Fluorescence Emission Spectra. Biophys. J. 90:3704-3711
77. Souillac PO, Uversky VN, Fink AL (2003) Structural transformations of oligomeric intermediates in the fibrillation of the immunoglobulin light chain LEN. Biochemistry 42: 8094-8104. (Pubitemid 36807726)
78. Heegaard NH, Jorgensen TJ, Rozlosnik N, Corlin DB, Pedersen PJS, et al. (2005) Unfolding, aggregation, and seeded amyloid formation of lysine-58-cleaved beta 2-microglobulin. Biochemistry 44: 4397-4407. (Pubitemid 40403981)
79. Pedersen JS, Dikov D, Flink JL, Hjuler HA, Christiansen G, et al. (2006) The changing face of glucagon fibrillation: structural polymorphism and conformational imprinting. J. Mol. Biol. 355; 501-523. (Pubitemid 41785753)
80. Dusa A, Kaylor J, Edridge S, Bodner N, Hong DP, et al. (2006) Characterization of Oligomers during α-Synuclein Aggregation Using Intrinsic Tryptophan FluorescenceBiochemistry,45(8):2752-2760
81. Chatani E, Kato M, Kawai T, Naiki H, Goto Y (2005) Main-chain Dominated Amyloid Structures Demonstrated by the Effect of High Pressure, J. Mol. Biol. 52(4):941-951. (Pubitemid 41267079)
82. Militello V, Vetri V, Leone M (2003) Conformational changes involved in thermal aggregation processes of bovine serum albumin. Biophys Chem;105(1):133-41. (Pubitemid 36970268)
83. Lindgren M, Sorgjerd K, Hammarstrom P (2005) Detection and characterization of aggregates, prefibrillaramyloidogenic oligomers, and protofibrils using fluorescence spectroscopy. Biophys J. 88: 4200-4212. (Pubitemid 40991131)
84. Bolognesi B, Kumita JR, Barros TP, Esbjorner EK, Luheshi LM, et al. (2010) ANS binding reveals common features of cytotoxic amyloid species. ACS Chem. Biol. 5: 735-740.
85. Kuznetsova IM, Sulatskaya AI, Povarova OI, Turoverov KK (2012) Reevaluation of ANS Binding to Human and Bovine Serum Albumins: Key Role of Equilibrium Microdialysis in Ligand - Receptor Binding Characterization; PloS ONE 7(7): e40845.
86. Holm NK, Jespersen SK, Thomassen LV, Wolff TY, Sehgal P, et al. (2007) Aggregation and fibrillation of bovine serum albumin. Biochimica et Biophysica Acta - Proteins and Proteomics, 1774 (9), 1128-1138. (Pubitemid 47333256)
87. Foderà V, Groenning M, Vetri V, Librizzi F, Spagnolo S, et al. (2008) Thioflavin T hydroxylation at basic pH and its effect on amyloid fibril detection. J PhysChem B. 112(47):15174-81
88. Robbins KJ, Liu G, Lin G, Lazo ND (2011) Detection of Strongly Bound Thioflavin T Species in Amyloid Fibrils by Ligand-Detected 1H NMR. J. Phys.Chem. Lett. 2: 7352740.
89. Robbins KJ, Liu G, Selmani V, Lazo ND (2012) Conformational analysis of thioflavin T bound to the surface of amyloid fibrils. Langmuir. 28: 16490-16495.
90. Smith MI, Foderà V, Sharp JS, Roberts CJ, Donald AM (2012) Factors affecting the formation of insulin amyloid spherulites. Colloids Surf B Biointerfaces. 89:216-22
91. Foderà V, Pagliara S, Otto O, Keyser UF. Donald AM (2012) Microfluidics Reveals a Flow-Induced Large-Scale Polymorphism of Protein Aggregates. The Journal of Physical Chemistry Letters 3 (19), 2803-2807